Uncategorized
NovaBay Pharmaceuticals Announces $2.83 Million Private Placement
EMERYVILLE, Calif.--(BUSINESS WIRE)--NovaBay® Pharmaceuticals, Inc. (NYSE MKT:NBY) a biopharmaceutical company focusing on commercializing its Avenova® Lid and Lash Cleanser for the domestic eye care market, announces that it has entered into three securities purchase agreements for the sale of 1,518,567 shares of common stock for approximately $2.83 million. Investors in the private placement include Mr. Jian Ping Fu and Pioneer Pharma (Singapore) Pte. Ltd. Mr. Fu is President of Greenwood Cap
